Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, April 8, 2024
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
[ Mon, Apr 08th 2024
] - WOPRAI
Fri, April 5, 2024
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
[ Fri, Apr 05th 2024
] - WOPRAI
Raghuram Selvaraju Reiterated (AQST) at Strong Buy and Held Target at $9 on, Apr 5th, 2024
Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aquestive Therapeutics, Inc." (AQST) at Strong Buy and Held Target at $9 on, Apr 5th, 2024.
Raghuram has made no other calls on AQST in the last 4 months.
There are 4 other peers that have a rating on AQST. Out of the 4 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.
These are the ratings of the 4 analyists that currently disagree with Raghuram
- Gary Nachman of "Raymond James" Initiated at Buy and Held Target at $7 on, Thursday, March 28th, 2024
- Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $10 on, Friday, March 15th, 2024
- Thomas Flaten of "Lake Street" Maintained at Strong Buy with Increased Target to $8 on, Thursday, March 7th, 2024
- Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
